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ABSTRACT 
Today Helicobacter pylori (H. pylori) infection is one of the very common bacterial infections worldwide. Upper gastro intestinal tract is 
primarily affected with this bacterial infection. H. pylori are primarily responsible for dyspepsia, gastric and duodenal ulcers and gastric 
carcinogenesis and obliteration of the infection has become an important treatment goal in clinical practice. Analysis of multi component 
formulations by any single analytical method is a very challenging task. A new, simple, precise, accurate, reproducible, and efficient UV 
spectrophotometric method is developed and validated for the simultaneous estimation of ternary mixture of amoxicillin (AMX), omeprazole 
(OMP) and rifabutin (RFB) in bulk and in a synthetic mixture which is recently approved by FDA in 2019 to be used for treatment of H. pylori by 
Vierordt’s method or simultaneous equation method. The solutions of standard and sample were prepared in 0.1 N HCl. The 𝜆max for AMX, 
OMP, and RFB were 230.0nm, 316.0nm, and 248.0nm, respectively. Calibration curves are linear in the concentration ranges 5-25𝜇g/ml for 
AMX, 1-5𝜇g/ml for OMP, and 1-5𝜇g/ml for RFB, respectively. Results of study of simultaneous equation method were analyzed and validated for 
various parameters consistent with ICH guidelines. 
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INTRODUCTION 
Helicobacter pylori (H. pylori) infection is extremely 
common worldwide. Around 40-50% of the world 
population affecting by this infection. H. pylori have been 
known as a group 1 carcinogen by the World health 
organization. According to World health organization H. 
pylori is associated with development of gastric cancer. 
Experimentally H. pylori obliteration has been demonstrated 
to have a prophylactic result against gastric cancer 1-4. In 
human beings positive effect of H. pylori obliteration in 
reducing gastric cancer incidence has been reported 5-7. The 
indications for H. pylori obliteration as proposed by an 
international agreement of experts (Maastricht III Consensus 
Report) 8, 9. The revised Maastricht guidelines endorsed all 
the previous indications for H. pylori treatment. Triple 
therapies used PPI, primarily omeprazole (OMP), combined 
with amoxicillin (AMX) and rifabutin (RFB), which are given 
four capsules every 8 hours with food for 14 days regimen 9. 
Omeprazole (OMP, Fig.1A) (RS)-6-methoxy-2-((4-methoxy-3, 
5-dimethylpyridin-2-yl) methyl sulfinyl)-1H-benzo (d) 
imidazole is a proton pump inhibitor (PPI) and an anti-
secretory compound. It works by suppressing gastric acid 
secretion by inhibiting the gastric H+ /K+ATPase (hydrogen-
potassium adenosine triphosphatase) at the secretory 
surface of the gastric parietal cell 10-12. OMP has been 
characterized as a gastric acid-pump inhibitor, in that it 
blocks the final step of acid production. After rapid 
disappearance from plasma, OMP can be found within the 
gastric mucosa for a day or more.  
It is freely soluble in ethanol and methanol, slightly soluble in 
acetone and isopropanol and very slightly soluble in water. 
In triple therapy for H. pylori, OMP is useful in combination 
with the antibiotics clarithromycin and amoxicillin (or 
metronidazole in penicillin-hypersensitive patients) in the 7-
14 day eradication. Literature survey suggested that there 
are some methods based on UV 13, HPTLC 14, capillary 
electrophoresis 15, HPLC 16-22 for the determination of OMP 
independently and in mixture with other drugs in dosage 
forms and biological fluids. Amoxicillin (AMX Fig. 1B) is a β-
lactam antibiotic drug which belongs to the group of 
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penicillin group drugs 23. It is a moderate-spectrum β-lactam 
antibiotic used to treat infections caused by penicillin-
sensitive Gram-positive bacteria as well as some Gram-
negative bacteria 24. AMX chemically as (2S, 5R, 6R) [[(2R)-2-
amino-2 (4 hydoxyphenyl) acetyl] amino]-3,3-dimethyl-7-
oxo-4-thia1-azabicyclo [3.2.0] heptanes-2-carboxyic acid 
25,26. Various spectrophotometric, 27-30 HPLC, 31-36 HPTLC 37 
and spectrofluorimetric 38 methods are reported in the 
literature for the estimation of AMX independently and in 
mixture with other drugs. Rifabutin (RFB Fig. 1C) is a 
synthetic derivative of rifamycin S isolated from 
Amycolatopsis rifamycinica that acts by inhibiting the DNA 
dependent RNA-polymerase of bacteria; it has been shown to 
have significant mycobactericidal (hence anti-tuberculosis) 
activity. RFB is a less potent microsomal enzyme inducer 
than rifampin, therefore it is the preferred rifamycin class 
antibiotic for treatment of TB in HIV-infected patients. RFB is 
readily absorbed from the gastrointestinal tract with a Cmax 
of about 375ng/ml reached 3.3h after a single 300-mg oral 
dose, under fasting conditions. RFB is actively degraded to its 
25-O-desacetyl derivative in vitro with an activity almost 
equivalent to that of its parent compound 39, 40. Few HPLC, 40-
44 and capillary electrophoresis 45 methods are reported in 
the literature for the estimation of RFB individually and in 
combination with other drugs. However, no 
spectrophotometric method has yet been reported for 
simultaneous estimation of AMX, OMP, and RFB in 
pharmaceutical dosage forms. These methods mentioned in 
the literature, especially the chromatographic techniques, 
are time-consuming, costly, and require expertise. A simple 
and accurate UV spectrophotometric method developed can 
be highly useful for the routine analysis of capsule 
formulations. Hence, an attempt has been made to develop 
and validate in accordance with ICH guidelines 46. 
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Figure 1 Chemical structure of (A) Omeprazole(B) Amoxicillin (C)Rifabutin 
 
EXPERIMENTAL 
Reagents and chemicals 
Reference standard of AMX, OMP and RFB was a generous 
gift from Bioplus life science, Bangalore. Methanol, 
acetonitrile, HCl was procured from Rankem, RFCL Limited, 
New Delhi, India. All solvents and reagents were of analytical 
grade. All the solutions were protected for light and were 
analyzed on the day of preparations. Triple distilled water 
was generated in house. Talicia capsule (AMX 
250mg/OMP10mg/RFB 12.5mg) was purchased from local 
market of Bhopal, India. Distilled water was obtained by Mili 
Q apparatus by Millipore (Milliford, USA) for whole 
experimental work. 
Instrument 
In UV-spectrophotometric method, Labindia model-3000+ 
series were used, which is a wavelength accuracy ±1 nm, 
with 1cm quartz cells. 
 
 
Method development 
Standard stock solution (Stock-A) 
For preparation of standard stock solutions, weigh and 
dissolve 100 mg of each drug in 100 ml volumetric flask 
separately. Add some amount of 0.1 N HCl as a solvent for 
solubilizing the drugs. The flask was sonicated for about 10 
minutes to solubilize the drug and the final volume was made 
up to the mark 100 ml with 0.1 N HCl to get a concentration 
of 1000 µg/ml (Stock-A) for each drugs. 
Sub stock solution (Stock-B) 
Aliquots of 2.5 ml withdrawn with help of pipette from 
standard stock solution Aof AMX, OMP and RFB and 
transferred into 25 ml volumetric flask separately and 
diluted up to 25 ml with 0.1 N HCl that gave concentration of 
100 µg/ml (Stock-B). 
Preparation of working standard solution 
0.5 ml, 1.0 ml, 1.5 ml, 2.0 ml and 2.5 ml from sub stock 
solution (Stock-B) were taken individually in 10 ml 
volumetric flask and volume was made up to 10 ml with 0.1 
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N HCl. This gave the working solutions of 5µg/ml, 10µg/ml, 
15µg/ml, 20µg/ml and 25µg/ml respectively for AMX. 1 
µg/ml, 2 µg/ml, 3 µg/ml, 4 µg/ml, 5 µg/ml of OMP and RFB 
also prepared in similar way. 
Selection of wavelength for linearity 
10µg/ml standard solutions of allAMX, OMP and RFBwere 
prepared from respective sub-stock solutions. The solutions 
were scanned in the wavelength region of 200-400 nm.The 
maximum absorbance of AMX, OMP and RFBwas observed at 
230.0 nm, 316.0nm and 248.0 nm, respectively.AMX showed 
linearity in the concentration range of 5-25 g/ml and OMP 
and RFB showed linearity 1-5g/ml at their respective 
maxima. Calibration curve was plotted, absorbance versus 
concentration (Figure2-4). 
 
 
Figure 2: Determination of λmaxof AMX 
 
 
Figure 3: Determination of λmaxof OMP 
 
 
Figure 4: Determination of λmaxof RFB 
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Figure 5: Overlay spectra of AMX, OMP and RFB 
 
Preparation of calibration curve 
Different aliquots were prepared from standard stock 
solution by dilution method. Pipette out the drug solution 
into a series of 10 ml volumetric flasks. Final volume was 
made up to the mark with the diluent to get a set of solutions 
having a concentration range of 5-25µg/ml for AMX and 1-
5µg/ml for OMP and RFB. Triplicate dilutions of each drug 
solutions were prepared separately. The prepared working 
solutions of AMX, OMP and RFBwere scanned 230.0 nm, 
316.0nm and 248.0 nm, respectively. The absorbance’s were 
recorded and were plotted against the concentrations to 
obtain their respective calibration curves.  
 
 
 
 
 
 
 
 
Simultaneous equation method
Simultaneous  equation  method  is  also  known  as 
vierodt's method. Absorption of drugs (d1, d2, and d3) at the 
wavelength maximum of the other is a fundamental principle 
of  this  method.  The  wavelength maximum  (λmax) of AMOX, 
OMPR  and  RIFB  were  determined  with  the  help  of  UV- 
spectroscopy  which  are 230.0  nm,  316.0nm  and  248.0nm 
respectively.
The absorbance’s were measured at the selected wavelengths 
and  absorptivities  (A1%,  1cm)  for  all  the  drugs  at 
appropriate wavelengths  were  determined  as  mean  of  five 
independent determinations.  Concentrations of  the  drugs
in  the  samplewere calculated by using following equations. 
 
 
Where,  A1, A2 and A3 are absorbances of AMOX, OMPR and RIFB at λ1, λ2 and λ3 
ax1, ax2 and ax3 are the absorptivity of AMOX at  λ1, λ2 and λ3 respectively 
ay1, ay2 and ay3 are the absorptivity of OMPR at  λ1, λ2 and λ3 respectively  
az1, az2 and az3 are the absorptivity of RIFB at  λ1, λ2 and λ3 respectively 
 
Mixed standard study 
Capsules of AMX, OMP and RFB combination are available in 
250:10:12.5mg. Mixed standard are prepared in the ratio of 
1:2 from standard sub stock solution of 10g/ml in 3 
replicate of 5 concentrations. Solutions containing known 
concentration of three drugs are considered as laboratory 
samples (mix standards) to check the results of developed 
method.  
Methods validation  
Validation of the method was carried out in accordance with 
the International Conference on Harmonization Q2B 
guidelines 2005 46.  
Linearity 
The linearity of analytical method was performed to confirm 
its capability to obtain test results that are directly 
proportional to the concentration of drug in sample within a 
specify range. Different levels of standard solutions were 
prepared and estimate into the UV and the results was 
recorded. The results of linearity are reported in table 1. 
Accuracy 
The accuracy of proposed method was evaluated by percent 
recovery studies. The recovery of the developed method was 
studied at 80%, 100% and 120% at three replicate and three 
concentrations level by standard addition method. The value 
of % means just close to 100, SD and % RSD are less than 2 
indicate the accuracy of method. Result of recovery study 
shown in table 2. 
Precision 
Precision is closeness between series of measurements. 
Repeatability and Intermediate precision were studied 
under this parameter. Repeatability result indicates the 
precision under the same operating condition over short 
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interval time. The intermediate precision study is expressed 
within laboratory variation on different days and analyst to 
analyst variation by different analyst. The value of SD and 
%RSD are less than 2 indicate the precision of method. 
Result of precision shown in table 3. 
Sample stock solution for assay 
The results of the analysis of synthetic mixture were 
reported. Ten tablets powdered equivalent were mixed in a 
ratio of 250: 10:12.5 mg. A quantity of this Synthetic mixture 
powder equivalent to 25mg of AMX (1.0mg OMP and 1.25 
mg RFB) was taken in 10 ml volumetric flask. Then 5ml of 
0.1 N HCl was added and the flask was sonicated for about 
10 min to solubilize the drug present in synthetic mixture 
and the volume was made up to the mark with 0.1 N HCl. 
Filter the solution using Whatman filter paper No. 41. 
Collect the filterate and further diluted with 0.1 N HCl to get 
the final concentrations of all drugs in the working range. 
The absorbances of final dilutions were observed at selected 
wavelengths and the concentrations were obtained from 
simultaneous equation method. The procedure was repeated 
for five times. The assay value of drugs was close to 100, SD 
and % RSD are less than 2 indicate the no interference of 
excipients in the estimation of drugs. 
 
Table 1 Results of Linearity of AMX, OMP and RFB 
Parameter AMX OMP RFB 
Concentration (μg/ml) 5-25 1-5 1-5 
Correlation Coefficient (r2)* 0.999 0.999 0.999 
Slope (m)* 0.021 0.089 0.101 
Intercept (c)* 0.002 0.004 0.002 
*value of three replicate 
Table 2 Results of recovery study 
% Level % MEAN±SD* 
 AMX OMP RFB 
80% 98.02±1.749 98.17±1.025 98.75±0.693 
100% 99.04±0.610 97.32±1.188 96.60±1.132 
120% 99.17±0.449 98.63±1.610 98.26±1.278 
* Value of three replicate and five concentrations 
Table 3 Results of precision 
Parameter 
% MEAN±SD* 
AMX OMP RFB 
Repeatability 98.865±0.126 95.589±0.110 96.195±0.098 
             Intermediate precision 
Day to day precision 99.139±0.093 96.141±0.096 97.362±0.096 
Analyst-to-Analyst  98.640±0.109 98.287±0.024 96.677±0.093 
Reproducibility 99.016± 0.101 96.007±0.117 97.237±0.076 
* Value of five replicate and five concentrations 
Table 4 Assay of capsule formulation 
Conc. Present (µg/ml) Mean % Conc. Found 
AMX OMP RFB AMX OMP RFB 
5 1 1 99.30 98.50 95.50 
10 2 2 99.15 98.50 97.75 
15 3 3 98.77 99.50 99.50 
20 4 4 99.35 96.75 97.13 
25 5 5 98.86 98.00 98.70 
 
Mean 99.09 98.25 97.72 
S.D 0.260 1.000 1.534 
*Average of three replicate and five concentrations 
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DISCUSSION 
The developed method was validated in accordance with the 
International Conference on Harmonization 46 guidelines. 
Parameters like precision, accuracy, specificity, linearity and 
range, robustness and ruggedness was studied for the 
proposed method. The high value of the correlation 
coefficients (𝑟 2 = 0.999 for AMX, 0.998 for OMP, and 0.999 
for RFB) confirmed the linearity of the calibration plots. 
Recovery was in the range of 98.26-99.17%; the values of 
standard deviation and % RSD were found to be less than 2 
showing the high accuracy of the method. Robustness and 
ruggedness were also carried out and percentage RSD was 
found to be less than 2.0%. The assay of AMX, OMP, and RFB 
was found to be 99.09%, 98.25%, and 97.72 %. Thus, the 
method provides a simple, convenient, rapid and accurate 
way to determine AMX, OMP, and RFBsimultaneously. 
CONCLUSION  
The vierodt's method has been successfully applied for 
simultaneous determination of AMX, OMP, and RFB in 
combined sample solution, and they were found to be 
accurate, simple, rapid, and precise. Once the equations were 
constructed, analysis required only measuring the 
absorbance values of the sample solution at the selected 
wavelengths followed by few simple calculations. The 
proposed method was completely validated showing 
satisfactory data for all the method validation parameters 
tested. Simultaneous equation method comparably noted to 
be very efficient in every aspect. Unlike HPLC, by using 
simultaneous equation method (UV) the data’s can be 
generated applying simple calculations. So these methods 
can be easily and conveniently adopted for routine quality 
control analysis of these cited drugs. 
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